Cargando…

Effects of α lipoic acid combined with olmesartan medoxomil on blood glucose and oxidation indicators in patients with diabetic nephropathy: A protocol for a parallel, randomized, double-blind, controlled clinical trial

BACKGROUND: Diabetic nephropathy (DN) is a common microvascular complication of diabetes, which poses a serious threat to the health and life of patients. There is evidence that both α lipoic acid and olmesartan medoxomil have positive effects in the treatment of DN, but whether the 2 have synergist...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiao, Shengfu, Dong, Yuxia, Chang, Xiang, Wu, Yanan, Li, Haifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276178/
https://www.ncbi.nlm.nih.gov/pubmed/35512068
http://dx.doi.org/10.1097/MD.0000000000029080